- ValGenesis has implemented its e-Logbook solution at LOTTE Biologics’ satellite QC lab to digitize quality operations.
- LOTTE Biologics plans to expand the system across its Songdo Bio Campus as part of its digital transformation strategy.
ValGenesis has announced the deployment of its e-Logbook solution at LOTTE Biologics, a contract development and manufacturing organization (CDMO) headquartered in Seoul, South Korea. The system has gone live at the company’s satellite quality control laboratory and is intended to support digital logbook management in regulated environments.
The implementation forms part of LOTTE Biologics’ broader digital transformation strategy. The company plans to extend the e-Logbook platform across its main laboratory and manufacturing operations at its Songdo Bio Campus, which is currently under development. The initiative aims to create a connected quality ecosystem and improve operational execution through digital workflows.
The e-Logbook solution replaces paper-based processes with digital forms accessible across devices. It supports features such as QR and barcode-based form selection, offline data capture, and automated workflows aligned with standard operating procedures. The system also provides role-based access, audit trails, and integration capabilities with enterprise systems including MES, QMS, LIMS, and CMMS.
“This project represents more than just a system implementation—it marks a meaningful transformation for LOTTE Biologics. By replacing paper-heavy QC processes with streamlined digital workflows, we have built a more efficient, reliable, and scalable environment that enhances quality management and prepares us for future growth.”
Hyunjin Cho, IT Team, LOTTE Biologics
LOTTE Biologics, founded in 2022, operates a Bio Campus in Syracuse, New York, and is developing a second site in Songdo, South Korea. The adoption of digital validation and compliance tools is intended to support the company’s contract manufacturing and CDMO operations as it expands its global biopharmaceutical manufacturing footprint.
